Coated central venous lines and catheter related blood stream infections

CPD Anaesthesia

Volumn 6, Issue 3, 2004, Pages 136-139

  Garg, Sudha ^a   Patel, Sheel ^b   Al Shaikh, Baha ^a  

^a WILLIAM HARVEY HOSPITAL   (United Kingdom)

^b William Harvey Hospital ^*

Author keywords

Catheter related blood stream infection; Central venous catheters; Equipment; Infection

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; BENZALKONIUM CHLORIDE; CEFAZOLIN; CHLORHEXIDINE; FIBRONECTIN; HEPARIN; MINOCYCLINE; PLATINUM; RIFAMPICIN; SILVER; SULFADIAZINE SILVER; TEICOPLANIN;

BACTEREMIA; BRAIN ABSCESS; CATHETER INFECTION; CENTRAL VENOUS CATHETERIZATION; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; CRITICAL ILLNESS; DRUG COATING; ENDOCARDITIS; ENDOPHTHALMITIS; HIGH RISK PATIENT; HOSPITAL COST; HUMAN; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; LUNG ABSCESS; MATERIAL COATING; META ANALYSIS; OSTEOMYELITIS; SEPSIS; SHORT SURVEY; THROMBOPHLEBITIS; THROMBOSIS; TOTAL PARENTERAL NUTRITION; UNITED KINGDOM;

EID: 14944363066     PISSN: 14662922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (23)

1. O'Grady N P, Alexander M, Dellinger E P, Gerberding J L, et al. (2002) Centers for Disease Control and Prevention. Guidelines for the Prevention of Intravascular Catheter-Related Infections. MMWR 51: RR-10,1-34.
2. National Audit Office (NAO) Improving patient care by reducing the risk of hospital acquired infection: A progress report by the Comptroller and Auditor General HC 876 Session 2003-2004: 14 July 2004.
3. CDC. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999. Am J Infect Control 1999; 27:520-32.
4. Mermal L A McCormick RD, Springman SR, Maki DG. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am J Med 1991; 91(suppl):S197-205.
5. Raad II, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis 1993; 168:400-7.
6. Maki DG. Infections associated with intravascular lines. In: Remington JS, ed. Current Clinical Topics in Infectious Diseases. New York: McGraw-ill, 982:309-63.
7. Guidelines for preventing infections associated with the insertion and maintenance of central venous catheters. Journal of Hospital Infection 2001; 47 (supplement):S47-S67.
8. Sheth NK, Franson TR, Rose HD, Buckmire FL, Cooper JA, Sohnle PG. Colonization of bacteria on polyvinyl chloride and Teflon intravascular catheters in hospitalized patients. J Clin Microbiol 1983; 18:1061-3.
9. Veenstra DL, Saint S, Saha S, Lumley T, Sullivan S. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 1999;281:261-267.
10. Maki DG, Ringer M, Alvarado CJ. Prospective randomized trial of povidone-iodine, alcohol and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991;338:339-343.
11. Trooskin SZ, Donetz AP, Harvey RA Prevention of catheter sepsis by antibiotic bonding. Surgery 1985; 97: 547-551.
12. Marin MG, Lee JC, Skurnick JH. Prevention of nosocomial bloodstream infections: effectiveness of antimicrobial-impregnated and heparin-bonded central venous catheters. Crit Care Med 2000; 28 3332-3338.
13. Russell LM, Weinstein RA. Antimicrobial-coated central venous catheters- Icing on the cake or the staff of life? Crit Care Med 1998;26(2): 195-196.
14. Haxhe JJ, D'Hoore. A meta-analysis dealing with the effectiveness of chlorhexidine and silver sulfadiazine impregnated central venous catheters. J Hosp Infect 1998;40:166-168.
15. Schierholz J. Central venous catheters and bloodstream infection. JAMA 2000;283(4):447.
16. Bassetti S, Hu J, D'Agostino RB Jr., Sherertz RJ. Prolonged antimicrobial activity of a catheter containing chlorhexidine/silver sulfadiazine extends protection against catheter infections in vivo. Antimicrob Agents Chemother 2001; 45:1535-1538.
17. Maki DG, Stolz SM, Wheelar S, Mermel LA. Prevention of central venous catheter- related bloodstream infection by use of an antiseptic-impregnated catheter. Ann Int Med 1997;127 257-266.
18. Darouiche RO, Raad II, Heard SO. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med 1999;340: 1-8.
19. Dahlberg PJ, Agger WA, Singer JR, et al. Subclavian hemodialysis catheter infections: a prospective, randomized trial of an attachable silver-impregnated cuff for prevention of catheter related infections. Infect Control Hosp Epidemiol 1995; 16:506-11
20. Timsit JF, Farkas JC, Boyer JM, et al. Central vein catheter related thrombosis in intensive care patients: incidence, risk factors, and relationship with catheter related sepsis. Chest 1998;114:207-13
21. Boraks P, Seale J, Price J, et al. Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with Haematological malignancies. Br J Haematol 1998; 101: 483-6.
22. Oda T, Hamasaki J, Kanda N, Mikami K. Anaphylactic shock induced by an antiseptic-coated central venous catheter. Anesthesiology 1997;87:1242-4.
23. Hanna HA, Raad II, Hackett B, Wallace SK, et al. Antibiotic-impregnated catheters associated with significant decrease in nosocomial and multidrug resistant bacteremias in critically ill patients. Chest 2003;124:1030-1038.